 |
|
|
| |
HIGH EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR (EBR/GZR) TREATMENT IN PATIENTS WITH HCV GENOTYPE 1A (GT1A) INFECTION IN GERMAN REAL-WORLD:
RESULTS FROM THE GERMAN HEPATITIS C REGISTRY (DHC-R)
|
| |
| |
Reported by Jules Levin
EASL 2019 April 10-14 Vienna
Holger Hinrichsen1, Albrecht Stoehr2, Markus Cornberg3, Hartwig Klinker4, Renate Heyne5, Christine John6, Karl-Georg Simon7, Manfred Bilzer8, Veronika Guenther9, Karen Martin9, Vanessa Witte9, Stefan Zeuzem10
1Gastroenterology-Hepatology Center Kiel, Kiel; 2ifi - Institute for Interdisciplinary Medicine, Study Centre St. Georg, Hamburg; 3Hannover Medical School, Hannover; 4University Hospital Wurzburg, Wurzburg; 5Leberzentrum am Checkpoint, Berlin;
6Private Practice of Internal Medicine, Berlin; 7MVZ Dres. Eisenbach, Simon, Schwarz GbR, Leverkusen; 8Bilzer Consulting, Munich; 9MSD Sharp & Dohme GmbH, Haar; 10Johann Wolfgang Goethe University, Frankfurt
|
| |
|
|
|
|
|
